Gabapentinoids in Chronic Kidney Disease: A Closer Look at Respiratory Risk
Gabapentinoid use in hospitalized CKD patients was associated with respiratory depression. These findings support the need for careful dosing and monitoring of gabapentinoids in this high-risk population.
Authors
- Christopher Giuliano (ORCID: https://orcid.org/0000-0002-0540-785X)
- Lauren T. Harven
- Renee Alexander Paxton
Institutions
- Eugene Applebaum College of Pharmacy and Health Sciences (US)
- Henry Ford Health System (US)
- Henry Ford Hospital (US)
Publication Details
- Journal
- Annals of Pharmacotherapy
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1177/10600280251401899
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 0.00